Skip to main content

Merrie Mosedale

October 3, 2018

Animal Models, Hepatocytes, High Content Imaging/Screening, Nanoparticle Tracking Analysis, Omics (Metabolomics, Proteomics, Lipidomics), Primary Cell Culture, Ultracentrifugation, Adverse Drug Reactions, Drug Safety, Drug-induced Liver Injury, Exosomes, Hepatology, Liver Disease, Medication Safety, Pharmacogenetics, Pharmacogenomics, Toxicology

Tim Wiltshire

October 3, 2018

Animal Models, DNA Sequencing, High Content Imaging/Screening, Omics (Metabolomics, Proteomics, Lipidomics), Primary Cell Culture, Adverse Drug Reactions, Clinical Education, Comparative Effectiveness, Medication Optimization, Metabolism, Pain, Pharmacoeconomics, Pharmacogenetics, Pharmacogenomics, Precision Dosing, Precision Health, Precision Medicine

Kenneth Pearce

September 24, 2018

Assay Development, Chemical Libraries, High Content Imaging/Screening, High Throughput Screening, Phage Display, Surface Plasmon Resonance, Biophysics, Cancer, Chemical Biology, Chemical Probes, Drug Discovery, Epigenetics, High Throughput Screens, Protein Expression, Protein Kinase Inhibitors, Protein engineering, Structure Activity Relationship

Bryan Roth

September 24, 2018

Chemogenetics, Directed Evolution, High Content Imaging/Screening, High Throughput Screening, X-ray Crystallography, Biased Agonism, Drug Discovery, Drug Safety, G Protein-coupled Receptors, Mental Health, Neuropharmacology, Neuroscience, Opioids, Pharmacology, Protein Chemistry, Protein Expression, Protein engineering, Structural Biology, Structure Activity Relationship, Structure-based Drug Dosing